In NPC, platelet-derived extracellular vesicles (EVs) enriched in integrin β3 (ITGB3) transferred this integrin into tumor cells, activating the MAPK/ERK/ATF4/Nrf2 axis [31]. This evidence concerns the gene NFE2L2 and nasopharyngeal carcinoma.